FDA approved Eli Lillys Mounjaro (tirzepatide) injection
Tirzepatide is a once-weekly injectable medication for weight loss and blood sugar control
Gross necropsy and histopathologic examination of animals receiving high-dose BPC-157 found no organ damage in liver, spleen, lung, kidney, brain, thymus, prostate, ovaries, or gastric wall
Lyophilized peptide vials and small-molecule oral preparations have different production economics, which is why $/mg varies almost 5 across the vendors we track
Semaglutide stands out as a reliable adjunct, providing that extra push toward achieving and maintaining weight goals
Side Effects of Mounjaro (Tirzepatide): What Patients Need to Know Mounjaro (tirzepatide) is a newer medication used to manage type 2 diabetes and weight loss